Literature DB >> 17115234

Identification of novel RANK polymorphisms and their putative association with low BMD among postmenopausal women.

J-M Koh1, B L Park, D J Kim, G S Kim, H S Cheong, T-H Kim, J-M Hong, H-I Shin, E K Park, S-Y Kim, H D Shin.   

Abstract

INTRODUCTION: Bone mineral density (BMD) is the major factor for determining bone strength, which is closely correlated to osteoporotic fracture risk and is largely determined by multiple genetic factors. The RANK (TNFRSF11A), receptor for RANKL, is a member of the tumor necrosis factor receptor (TNFR) superfamily and plays a central role in osteoclast development.
METHODS: In order to investigate the effects of RANK polymorphism on BMD and osteoporosis, we directly sequenced the RANK gene in 24 Korean individuals and identified 25 sequence variants. Eleven of these polymorphisms were selected and genotyped in a larger-scale study of postmenopausal women (n = 560). Areal BMD (g/cm(2)) of the anterior-posterior lumbar spine and the nondominant proximal femur were measured using dual-energy X-ray absorptiometry.
RESULTS: We found that two intronic polymorphisms in the RANK gene [RANK + 34863G > A (rs12458117) and RANK + 35928insdelC (new polymorphism found in this study) in intron 6] were significantly associated with the BMD of the lumbar spine, i.e., rare alleles were significantly associated with low BMD of the lumbar spine among Korean postmenopausal women (p = 0.04 and 0.02, respectively). These polymorphisms were also associated with low BMD of proximal femur sites, including Ward's triangle, trochanter, and total femur. Our results suggest that +34863G > A and +35928insdelC polymorphisms in RANK are possible genetic factors for low BMD in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17115234     DOI: 10.1007/s00198-006-0244-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  46 in total

Review 1.  Genetics of osteoporosis.

Authors:  J A Eisman
Journal:  Endocr Rev       Date:  1999-12       Impact factor: 19.871

Review 2.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

3.  Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis.

Authors:  A E Hughes; S H Ralston; J Marken; C Bell; H MacPherson; R G Wallace; W van Hul; M P Whyte; K Nakatsuka; L Hovy; D M Anderson
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

4.  Polymorphisms of the interleukin-6 gene are associated with bone mineral density.

Authors:  R E Murray; F McGuigan; S F Grant; D M Reid; S H Ralston
Journal:  Bone       Date:  1997-07       Impact factor: 4.398

Review 5.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

6.  Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin.

Authors:  N A Morrison; R Yeoman; P J Kelly; J A Eisman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  Prediction of bone density from vitamin D receptor alleles.

Authors:  N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

8.  Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation.

Authors:  Mary Karst; Genevieve Gorny; Rachelle J Sells Galvin; Merry Jo Oursler
Journal:  J Cell Physiol       Date:  2004-07       Impact factor: 6.384

9.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Authors:  D M Anderson; E Maraskovsky; W L Billingsley; W C Dougall; M E Tometsko; E R Roux; M C Teepe; R F DuBose; D Cosman; L Galibert
Journal:  Nature       Date:  1997-11-13       Impact factor: 49.962

10.  Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors.

Authors:  F Arai; T Miyamoto; O Ohneda; T Inada; T Sudo; K Brasel; T Miyata; D M Anderson; T Suda
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

View more
  4 in total

Review 1.  Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.

Authors:  Qing Xiong; Yan Jiao; Karen A Hasty; S Terry Canale; John M Stuart; Wesley G Beamer; Hong-Wen Deng; David Baylink; Weikuan Gu
Journal:  Genomics       Date:  2009-01-14       Impact factor: 5.736

2.  Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women.

Authors:  P Tu; P Duan; R-S Zhang; D-B Xu; Y Wang; H-P Wu; Y-H Liu; L Si
Journal:  Osteoporos Int       Date:  2014-08-20       Impact factor: 4.507

3.  Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians.

Authors:  Shan-Shan Dong; Xiao-Gang Liu; Yuan Chen; Yan Guo; Liang Wang; Jian Zhao; Dong-Hai Xiong; Xiang-Hong Xu; Robert R Recker; Hong-Wen Deng
Journal:  Calcif Tissue Int       Date:  2009-05-21       Impact factor: 4.333

Review 4.  Genetics of osteoporosis: accelerating pace in gene identification and validation.

Authors:  Wen-Feng Li; Shu-Xun Hou; Bin Yu; Meng-Meng Li; Claude Férec; Jian-Min Chen
Journal:  Hum Genet       Date:  2009-12-12       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.